OYLER JOHN 4

What Happened
John Oyler, CEO of BeOne Medicines (ONC), exercised stock derivatives and immediately sold the resulting shares in open-market transactions on July 15–16, 2026. He exercised 283,154 shares across several option/derivative lots (examples: 35,605 @ $100.04; 76,677 @ $169.58; 96,501 @ $160.40; 70,096 @ $119.96), paying roughly $41.14 million in exercise costs. He sold 283,154 shares in multiple transactions at prices roughly in the $310–$323 range, generating approximately $89.35 million in gross proceeds. The exercised-and-sold share counts match, indicating the exercised shares were sold immediately (a cashless-style outcome).

Key Details

• Transaction dates: July 15–16, 2026. Form filed July 17, 2026 (timely).
• Exercise (acquired): 283,154 shares; total cash paid ≈ $41.14M (various exercise prices listed in form).
• Open-market sales (disposed): 283,154 shares; total proceeds ≈ $89.35M; reported sale prices (weighted averages) ranged roughly $309.31 to $323.63 across multiple transactions.
• Additional derivative entries: the filing also shows several "exercise/conversion" line items recorded as disposed at $0 (totaling 3,681,002 shares reported as disposed at $0) — these are recorded as derivative conversions in the filing.
• Notable footnotes: sales were effected under a Rule 10b5-1 trading plan adopted March 10, 2026 (F7); each American Depositary Share (ADS) represents 13 ordinary shares (F6); several footnotes note weighted-average prices across multiple trades and trust/IRA holdings where the reporting person disclaims beneficial ownership (F1–F5, F10–F23).
• Post-transaction holdings: the filing extract provided here does not state Oyler’s total holdings after these transactions.

Context

• For retail investors: purchases (insider buys) are often taken as a stronger forward-looking signal than routine sales. This filing shows an exercise followed by immediate sales (common when insiders exercise options and sell shares to cover exercise/tax costs).
• Derivative explanation: the filing records multiple option/derivative exercises (code M). When exercised shares are sold the same day, it functions like a cashless exercise—insider converts options into shares and sells them rather than holding new shares.
• If you want full trade-by-trade pricing or to confirm post-transaction holdings, consult the full Form 4 on the SEC EDGAR site (accession 0001042047-26-000014) and the filing footnotes for the precise breakdown of weighted-average prices.